122 related articles for article (PubMed ID: 22010545)
1. A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system.
Lai PL; Panatto D; Gasparini R
J Prev Med Hyg; 2011 Sep; 52(3):142-3. PubMed ID: 22010545
[No Abstract] [Full Text] [Related]
2. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
3. Influenza vaccination coverage rates from 2006 to 2011 and the influence of the H1N1 pandemic on it in Austrian children.
Voitl PK; Schneeberger V
Klin Padiatr; 2011 Jul; 223(4):249-50. PubMed ID: 21630177
[No Abstract] [Full Text] [Related]
4. Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
Ajelli M; Merler S; Pugliese A; Rizzo C
Epidemiol Infect; 2011 Jan; 139(1):68-79. PubMed ID: 20546633
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
[TBL] [Abstract][Full Text] [Related]
6. Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.
Seyler T; Bella A; Puzelli S; Donatelli I; Rizzo C;
Vaccine; 2012 Jan; 30(2):109-11. PubMed ID: 22100893
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from the H1N1 pandemic: the need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy.
Colombatti R; Perrotta S; Masera N; Palazzi G; Notarangelo LD; Pusiol A; Bonetto E; De Zen L; Nocerino A; Samperi P; Russo-Mancuso G; Sainati L
Vaccine; 2011 Feb; 29(6):1126-8. PubMed ID: 21147126
[TBL] [Abstract][Full Text] [Related]
8. [The pandemic A/H1N1 in 2009 milder than regular seasonal influenza. Report from Uppsala County].
Sylvan S; Christenson B; Ardung B; Hedlund J; Pauksen K; Tverin I; Berglund L
Lakartidningen; 2012 Jun 5-19; 109(23-24):1156-8. PubMed ID: 22834207
[No Abstract] [Full Text] [Related]
9. [The influenza pandemic in a Norwegian municipality autumn 2009].
Rørtveit S; Hunskår S; Wensaas KA; Simonsen KA; Rørtveit G
Tidsskr Nor Laegeforen; 2011 Apr; 131(7):675-9. PubMed ID: 21494301
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010.
Brammer L; Blanton L; Epperson S; Mustaquim D; Bishop A; Kniss K; Dhara R; Nowell M; Kamimoto L; Finelli L
Clin Infect Dis; 2011 Jan; 52 Suppl 1():S27-35. PubMed ID: 21342896
[TBL] [Abstract][Full Text] [Related]
11. [The flu: should all be vaccinated?].
Cisterna R
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():29-31. PubMed ID: 20084347
[No Abstract] [Full Text] [Related]
12. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain.
Rodríguez-Rieiro C; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; Iniesta-Fornies D; Barranco-Ordoñez D; Cameno-Heras M; Jiménez-García R
Vaccine; 2011 Feb; 29(6):1332-8. PubMed ID: 21182996
[TBL] [Abstract][Full Text] [Related]
13. The sponsored pandemic of the Mexican flu?
Bijl D; Schellekens H
Int J Risk Saf Med; 2011; 23(2):73-9. PubMed ID: 21673414
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
[TBL] [Abstract][Full Text] [Related]
15. [Well-functioning strategy for the A/H1N1 pandemic in Varmland. A preliminary summary].
Wik O
Lakartidningen; 2010 Jun 16-29; 107(24-25):1630-3. PubMed ID: 20687426
[No Abstract] [Full Text] [Related]
16. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.
Liang XF; Li L; Liu DW; Li KL; Wu WD; Zhu BP; Wang HQ; Luo HM; Cao LS; Zheng JS; Yin DP; Cao L; Wu BB; Bao HH; Xu DS; Yang WZ; Wang Y
N Engl J Med; 2011 Feb; 364(7):638-47. PubMed ID: 21288090
[TBL] [Abstract][Full Text] [Related]
17. Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir.
Souza TM; Mesquita M; Resende P; Machado V; Gregianini TS; Fernandes SB; Oliveira IC; Rosa Mdo C; Marinelli R; de Azeredo-Lima CH; Motta FC; Aguiar-Oliveira Mde L; Siqueira MM
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):98-9. PubMed ID: 21784597
[No Abstract] [Full Text] [Related]
18. Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic.
Lai PL; Panatto D; Ansaldi F; Canepa P; Amicizia D; Patria AG; Gasparini R
Hum Vaccin; 2011; 7 Suppl():217-25. PubMed ID: 21922688
[TBL] [Abstract][Full Text] [Related]
19. [The 2009/2010 pandemic].
Schaberg T; Burger R
Pneumologie; 2010 Dec; 64(12):755-67; quiz 768. PubMed ID: 21128196
[No Abstract] [Full Text] [Related]
20. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
